What happens to tears inside the efferent lacrimal passage? An animal experimental study
- PMID: 10943674
- DOI: 10.1007/pl00007890
What happens to tears inside the efferent lacrimal passage? An animal experimental study
Abstract
Background: To determine whether absorption of protein components of the tear fluid occurs in normal efferent tear ducts, an animal experiment was carried out.
Methods: Iodinated albumin was dropped into eyes of female rats. After 10, 20 or 60 min the rats were killed, blood collected and the heads embedded for histological examination. Serum was obtained from the clotted blood and the radioactivity in a protein sediment and the combined supernatants counted. In a second approach, serum was fractionated by molecular mass and radioactivity in the fractions measured. Furthermore, autoradiographs of rat head sections were performed.
Results: Uptake of radioactivity into the serum was low, but increased with time. After 60 min maximal incorporation of the applied radioactivity into the blood was 0.13%; most (70-80%) of the incorporated radioactivity was not protein bound. Gel chromatographic separation according to molecular mass yielded fractionated peaks of radioactivity corresponding to albumin with maximal 4.8 Bq/ml serum, iodinated tyrosine (5.5 Bq/ml), and free iodine (237 Bq/ml; each after 60 min). Histologically the rat efferent lacrimal tear ducts showed a multilayered lining epithelium with integrated goblet cells in a characteristic arrangement of several cells. In autoradiographs of rat head sections no transport of radioactivity could be visualized.
Conclusion: In rats only traces of iodinated albumin are incorporated from the efferent lacrimal tear ducts into the blood. A higher proportion of the radioactivity is taken up as the proteolytic degradation product of bovine serum albumin to free amino acids, and 96% of the radioactivity incorporated was free iodine, probably as a contaminant of the iodinated preparation.
Similar articles
-
Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts.Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3137-43. Invest Ophthalmol Vis Sci. 2002. PMID: 12356816
-
The human nasolacrimal ducts.Adv Anat Embryol Cell Biol. 2003;170:III-XI, 1-106. Adv Anat Embryol Cell Biol. 2003. PMID: 12645158 Review.
-
[Tear outflow. Impact of mucins and TFF-peptides].Ophthalmologe. 2004 Jan;101(1):19-24. doi: 10.1007/s00347-003-0842-y. Ophthalmologe. 2004. PMID: 14872263 Review. German.
-
TFF peptides in the human efferent tear ducts.Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3359-64. Invest Ophthalmol Vis Sci. 2002. PMID: 12407144
-
Characterization of mucins in human lacrimal sac and nasolacrimal duct.Invest Ophthalmol Vis Sci. 2003 May;44(5):1807-13. doi: 10.1167/iovs.02-0744. Invest Ophthalmol Vis Sci. 2003. PMID: 12714609
Cited by
-
Malformation of Tear Ducts Underlies the Epiphora and Precocious Eyelid Opening in Prickle 1 Mutant Mice: Genetic Implications for Tear Duct Genesis.Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):6. doi: 10.1167/iovs.61.13.6. Invest Ophthalmol Vis Sci. 2020. PMID: 33141892 Free PMC article.
-
The value of lacrimal scintillography in the assessment of patients with epiphora.Eye (Lond). 2017 Jul;31(7):1020-1026. doi: 10.1038/eye.2017.20. Epub 2017 Mar 3. Eye (Lond). 2017. PMID: 28257135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical